Published in AAPS PharmSci on January 01, 2001
A Golgi-localized hexose transporter is involved in heterotrimeric G protein-mediated early development in Arabidopsis. Mol Biol Cell (2006) 1.11
Identification of functional SNPs in the 5-prime flanking sequences of human genes. BMC Genomics (2005) 1.07
Identification of specific transmembrane residues and ligand-induced interface changes involved in homo-dimer formation of a yeast G protein-coupled receptor. Biochemistry (2009) 0.81
Single nucleotide polymorphisms of the human M1 muscarinic acetylcholine receptor gene. AAPS PharmSci (2001) 0.76
Lower rate of genomic variation identified in the trans-membrane domain of monoamine sub-class of Human G-Protein Coupled Receptors: the Human GPCR-DB Database. BMC Genomics (2004) 0.76
Angiotensin type 1 receptor resistance to blockade in the opossum proximal tubule cell due to variations in the binding pocket. Am J Physiol Renal Physiol (2013) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The sequence of the human genome. Science (2001) 101.55
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (1996) 26.19
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (1996) 18.53
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (1995) 17.42
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (1996) 11.21
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A (2000) 10.27
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature (2000) 10.04
Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature (1998) 7.43
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (2001) 5.51
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature (1998) 5.24
GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature (1998) 5.03
Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet (1995) 4.97
G-protein-coupled receptor heterodimerization modulates receptor function. Nature (1999) 4.73
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell (1994) 4.35
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13
Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol (1993) 3.50
Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science (1997) 3.36
Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol (1995) 3.27
Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem (2000) 3.22
A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med (1996) 3.20
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (1993) 3.19
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol (1993) 3.19
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet (1995) 3.08
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest (2000) 3.00
Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem (1996) 2.99
The two-state model of receptor activation. Trends Pharmacol Sci (1995) 2.99
Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature (1993) 2.91
Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science (2000) 2.87
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest (1997) 2.85
Constitutively active mutants of rhodopsin. Neuron (1992) 2.84
A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem (1993) 2.78
A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem (1999) 2.78
A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science (1995) 2.78
A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature (1993) 2.68
Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci (1993) 2.59
Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci U S A (1989) 2.51
CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet (1998) 2.45
Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem (1994) 2.34
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med (1996) 2.30
Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature (1992) 2.30
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet (1994) 2.23
Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol (1994) 2.22
Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest (1995) 2.17
Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet (2000) 2.05
Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet (1999) 1.95
Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet (1993) 1.93
Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J Neurochem (1995) 1.93
G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci U S A (1991) 1.90
Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology (1998) 1.83
The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet (1996) 1.82
Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry (1993) 1.80
Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature (1994) 1.73
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (2000) 1.70
Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem (1994) 1.68
Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab (1999) 1.67
Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry (1999) 1.66
A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem (2000) 1.65
Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. J Biol Chem (1993) 1.64
Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature (2000) 1.63
High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature (2000) 1.60
Diversity and selectivity of receptor-G protein interaction. Annu Rev Pharmacol Toxicol (1996) 1.58
Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet (1993) 1.56
Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem (1993) 1.55
The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling. J Biol Chem (1998) 1.54
Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. J Neurochem (2001) 1.53
Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol Psychiatry (1997) 1.53
Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest (1998) 1.52
A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene (1999) 1.49
The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors. AAPS PharmSci (1999) 1.47
Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics (1996) 1.43
Defects in G protein-coupled signal transduction in human disease. Annu Rev Physiol (1996) 1.39
Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation (2000) 1.36
Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics (1995) 1.35
Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J Clin Invest (1993) 1.34
Activating mutations of rhodopsin and other G protein-coupled receptors. Annu Rev Biophys Biomol Struct (1996) 1.31
Expanding horizons for receptors coupled to G proteins: diversity and disease. Curr Opin Cell Biol (1994) 1.30
Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J (1994) 1.25
The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol (1997) 1.25
Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest (1994) 1.23
Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). J Pharmacol Exp Ther (2000) 1.23
Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol (1996) 1.21
Inverse agonism and the regulation of receptor number. Trends Pharmacol Sci (1997) 1.21
Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci (1994) 1.20
Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem (1994) 1.16
Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest (1996) 1.13
Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res (1999) 1.12
The role of GTP-binding proteins in signal transduction: from the sublimely simple to the conceptually complex. Curr Top Cell Regul (1992) 1.12
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci (1999) 1.10
A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun (1999) 1.10
Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J Biol Chem (1995) 1.10
G-protein-independent signaling by G-protein-coupled receptors. Trends Neurosci (2000) 1.10
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell (1985) 10.13
Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci U S A (1988) 7.48
The genome of the sea urchin Strongylocentrotus purpuratus. Science (2006) 6.41
ZnO nanowire UV photodetectors with high internal gain. Nano Lett (2007) 6.06
Retroversion of the acetabulum. A cause of hip pain. J Bone Joint Surg Br (1999) 5.93
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell (1998) 5.92
Jak2 is essential for signaling through a variety of cytokine receptors. Cell (1998) 5.92
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci U S A (1987) 5.68
High-speed mapping of synaptic connectivity using photostimulation in Channelrhodopsin-2 transgenic mice. Proc Natl Acad Sci U S A (2007) 5.42
Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet (1999) 4.79
Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J Am Chem Soc (2001) 4.46
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17
Safety Climate Survey: reliability of results from a multicenter ICU survey. Qual Saf Health Care (2005) 3.95
Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ (2006) 3.95
Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J Virol (1986) 3.65
Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity (1999) 3.53
[Tocolysis with nifedipine: its use in current practice]. Gynecol Obstet Fertil (2005) 3.30
SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell (1999) 3.15
Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J (2009) 3.05
A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron (1999) 2.82
In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82
Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology (2008) 2.79
Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation (1996) 2.77
Ecology. Giant pandas in a changing landscape. Science (2001) 2.73
Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem (2000) 2.70
A first attempt to prevent amblyopia and squint by spectacle correction of abnormal refractions from age 1 year. Br J Ophthalmol (1985) 2.65
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol Cell (2000) 2.41
Self-rated health and survival: a 7-year follow-up study of Australian elderly. Am J Public Health (1994) 2.37
The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci (2000) 2.28
Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem (1998) 2.26
Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials (2000) 2.24
SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell (1999) 2.19
Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nat Neurosci (1999) 2.17
Quantum-state controlled chemical reactions of ultracold potassium-rubidium molecules. Science (2010) 2.15
Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J Clin Psychiatry (1996) 2.14
Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group. Arch Intern Med (1998) 2.12
Integrin alpha8beta1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell (1997) 2.09
Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med (2000) 2.09
A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess (2013) 2.09
Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J Virol (2001) 2.08
Six mouse alpha-tubulin mRNAs encode five distinct isotypes: testis-specific expression of two sister genes. Mol Cell Biol (1986) 2.07
Umbilical cord mesenchymal stem cell transplantation in drug-induced Stevens-Johnson syndrome. J Eur Acad Dermatol Venereol (2012) 2.03
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci U S A (1996) 2.02
A prospective study of surgeon-performed ultrasound as the primary adjuvant modality for injured patient assessment. J Trauma (1995) 2.01
Prevalence of antibodies to the hepatitis E virus in pigs from countries where hepatitis E is common or is rare in the human population. J Med Virol (1999) 2.01
Attributable causes of cancer in China. Ann Oncol (2012) 1.98
The mammalian beta-tubulin repertoire: hematopoietic expression of a novel, heterologous beta-tubulin isotype. J Cell Biol (1986) 1.97
Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol (1987) 1.97
GreA-induced transcript cleavage in transcription complexes containing Escherichia coli RNA polymerase is controlled by multiple factors, including nascent transcript location and structure. J Biol Chem (1994) 1.92
Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine. J Biol Chem (1999) 1.91
Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol (2001) 1.86
Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol (1996) 1.86
Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. J Mol Biol (1985) 1.81
Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem (2000) 1.79
Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail (2001) 1.78
Quantitative analysis of transcriptional pausing by Escherichia coli RNA polymerase: his leader pause site as paradigm. Methods Enzymol (1996) 1.78
Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidney. J Cell Biol (2001) 1.77
C/EBP alpha:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBP alpha homodimers or AP-1. Oncogene (2007) 1.75
Skeletor, a novel chromosomal protein that redistributes during mitosis provides evidence for the formation of a spindle matrix. J Cell Biol (2000) 1.71
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem (2000) 1.70
Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem (2000) 1.69
A genomic view of the sea urchin nervous system. Dev Biol (2006) 1.68
Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection. J Clin Virol (2008) 1.68
Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. Euro Surveill (2013) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate. J Biol Chem (2000) 1.63
Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res (2000) 1.61
Molecular analysis of the SNF2/SWI2 protein family member MOT1, an ATP-driven enzyme that dissociates TATA-binding protein from DNA. Mol Cell Biol (1997) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Pulmonary atresia with intact ventricular septum: predictors of early and medium-term outcome in a population-based study. J Thorac Cardiovasc Surg (2005) 1.55
Teething and tooth eruption in infants: A cohort study. Pediatrics (2000) 1.55
COPD in Chinese nonsmokers. Eur Respir J (2009) 1.52
Churg-Strauss syndrome associated with zafirlukast. Chest (1998) 1.50
Multiple interactions stabilize a single paused transcription intermediate in which hairpin to 3' end spacing distinguishes pause and termination pathways. J Mol Biol (1997) 1.49
Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr (1998) 1.49
Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J (1995) 1.49
GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet (1998) 1.49
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol (2000) 1.48
Association analysis between mood disorder and monoamine oxidase gene. Am J Med Genet (2000) 1.48
Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation (1992) 1.46
Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Health Technol Assess (2012) 1.45
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design. Eur Respir J (2006) 1.45
Light-up probes: thiazole orange-conjugated peptide nucleic acid for detection of target nucleic acid in homogeneous solution. Anal Biochem (2000) 1.44
Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer. J Urol (1989) 1.42
Espin contains an additional actin-binding site in its N terminus and is a major actin-bundling protein of the Sertoli cell-spermatid ectoplasmic specialization junctional plaque. Mol Biol Cell (1999) 1.42
Enhanced patency of venous Dacron grafts by endothelial cell sodding. Ann Vasc Surg (1993) 1.41
Mitral valve replacement with complete mitral leaflet retention: operative techniques. J Heart Valve Dis (1999) 1.38
Characterization of nanoscale mechanical heterogeneity in a metallic glass by dynamic force microscopy. Phys Rev Lett (2011) 1.38
Computer-assisted three-dimensional surgical planning and simulation: 3D virtual osteotomy. Int J Oral Maxillofac Surg (2000) 1.38
Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J Virol (1988) 1.37
Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J Neurosci (2011) 1.37
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem (2001) 1.36
Cardiovascular phenotyping of fetal mice by noninvasive high-frequency ultrasound facilitates recovery of ENU-induced mutations causing congenital cardiac and extracardiac defects. Physiol Genomics (2005) 1.35
Poliovirus single-stranded RNA and double-stranded RNA: differential infectivity in enucleate cells. J Virol (1978) 1.33
Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem (2000) 1.33
Crafting the magnonic and spintronic response of BiFeO3 films by epitaxial strain. Nat Mater (2013) 1.33
Acupuncture for chronic low back pain in older patients: a randomized, controlled trial. Rheumatology (Oxford) (2003) 1.32
Mechanisms of spectral tuning in blue cone visual pigments. Visible and raman spectroscopy of blue-shifted rhodopsin mutants. J Biol Chem (1998) 1.32
A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. Genes Dev (2000) 1.32